Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.

[1]  R. Barakat,et al.  Epithelial ovarian cancer in the elderly: The memorial sloan‐kettering cancer center experience , 2010 .

[2]  L. Ries,et al.  Ovarian cancer: Survival and treatment differences by age , 2010, Cancer.

[3]  A. Neugut,et al.  Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Weinstein,et al.  Impact of referral patterns on the use of chemotherapy for lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Hansen,et al.  Performance status rather than age is the key prognostic factor in second‐line treatment of elderly patients with epithelial ovarian carcinoma , 2002, Cancer.

[6]  A. Neugut,et al.  Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer , 2002, Annals of Internal Medicine.

[7]  A. Whittemore,et al.  Race, Epithelial Ovarian Cancer Survival, and Membership in a Large Health Maintenance Organization , 2002, Epidemiology.

[8]  A. Whittemore,et al.  Survival among U.S. women with invasive epithelial ovarian cancer. , 2002, Gynecologic oncology.

[9]  M. Weinstein,et al.  Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[11]  M. Piccart,et al.  Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. , 2000, Journal of the National Cancer Institute.

[12]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[13]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[14]  R. Kronmal,et al.  Assessing the sensitivity of regression results to unmeasured confounders in observational studies. , 1998, Biometrics.

[15]  B. Kramer,et al.  Trends and black/white differences in treatment for nonmetastatic prostate cancer. , 1998, Medical care.

[16]  E. Trimble,et al.  Patterns of care for women with ovarian cancer in the United States. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[18]  R. Yancik.  Cancer burden in the aged , 1997, Cancer.

[19]  M. Schapira,et al.  Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. , 1997, Journal of clinical epidemiology.

[20]  D B Rubin,et al.  Matching using estimated propensity scores: relating theory to practice. , 1996, Biometrics.

[21]  E. Partridge,et al.  Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer , 1996, The New England journal of medicine.

[22]  Robert C. Bast,et al.  Ovarian cancer: screening, treatment, and followup. , 1995, NIH consensus statement.

[23]  A. Rademaker,et al.  Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Elixhauser,et al.  Black/white differences in colorectal tumor location in a national sample of hospitals. , 1994, Journal of the National Medical Association.

[25]  P. Novotny,et al.  Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Averette,et al.  National survey of ovarian carcinoma IV: Patterns of care and related survival for older patients , 1994, Cancer.

[27]  L. Kessler,et al.  Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database , 1993, Medical care.

[28]  D. Alberts,et al.  Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. , 1991, BMJ.

[29]  E. Yordan,et al.  Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Elashoff,et al.  Patterns of care related to age of breast cancer patients. , 1987, JAMA.

[31]  T. Brummer,et al.  Prognostic factors of advanced colorectal cancer patients. , 1986, European journal of cancer & clinical oncology.

[32]  J. Samet,et al.  Choice of cancer therapy varies with age of patient. , 1986, JAMA.

[33]  E. Yordan,et al.  A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study , 1986, Cancer.

[34]  W. G. Cochran.  The effectiveness of adjustment by subclassification in removing bias in observational studies. , 1968, Biometrics.

[35]  A. Neugut,et al.  Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  D. Alberts,et al.  Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer. , 1993, Oncology.

[37]  D. Rubin,et al.  Assessing Sensitivity to an Unobserved Binary Covariate in an Observational Study with Binary Outcome , 1983 .